Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanuja Shet

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Virchows Archiv : an International Journal of Pathology|July 16, 2025
Indirect clinical validation for predictive biomarkers in oncology: International Quality Network for Pathology (IQN Path) Position PaperEmina E Torlakovic, Raed Al Dieri, Tony Badrick, et al.
Scientific Reports|November 4, 2025
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patientsKhusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, et al.
Head & Neck|December 16, 2015
Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urineManju Sengar, Siddhesh Chorghe, Kamini Jadhav, et al.
Frontiers in Oncology|March 18, 2022
Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in IndiaPrashant R Tembhare, Gaurav Chatterjee, Anumeha Chaturvedi, et al.
Indian Journal of Pathology & Microbiology|March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiencesSushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Breast Cancer Research and Treatment|July 12, 2025
Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancerRohan Chaubal, Elizabeth Talker, Jaya Chitra, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agentManasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled TrialSudeep Gupta, Nita Nair, Rohini W Hawaldar, et al.
JCO Global Oncology|April 23, 2025
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyMinit Shah, Sushmita Rath, Seema Gulia, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Virchows Archiv : an International Journal of Pathology|July 16, 2025
Indirect clinical validation for predictive biomarkers in oncology: International Quality Network for Pathology (IQN Path) Position PaperEmina E Torlakovic, Raed Al Dieri, Tony Badrick, et al.
Scientific Reports|November 4, 2025
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patientsKhusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, et al.
Head & Neck|December 16, 2015
Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urineManju Sengar, Siddhesh Chorghe, Kamini Jadhav, et al.
Frontiers in Oncology|March 18, 2022
Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in IndiaPrashant R Tembhare, Gaurav Chatterjee, Anumeha Chaturvedi, et al.
Indian Journal of Pathology & Microbiology|March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiencesSushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Breast Cancer Research and Treatment|July 12, 2025
Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancerRohan Chaubal, Elizabeth Talker, Jaya Chitra, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agentManasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled TrialSudeep Gupta, Nita Nair, Rohini W Hawaldar, et al.
JCO Global Oncology|April 23, 2025
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyMinit Shah, Sushmita Rath, Seema Gulia, et al.
Pageof 18